LV5499A3 - Adaptation of 2-thienyloxyethyl derivatives or their pharmaceutically acceptable islands - Google Patents

Adaptation of 2-thienyloxyethyl derivatives or their pharmaceutically acceptable islands

Info

Publication number
LV5499A3
LV5499A3 LV931245A LV931245A LV5499A3 LV 5499 A3 LV5499 A3 LV 5499A3 LV 931245 A LV931245 A LV 931245A LV 931245 A LV931245 A LV 931245A LV 5499 A3 LV5499 A3 LV 5499A3
Authority
LV
Latvia
Prior art keywords
thienyloxyethyl
islands
adaptation
derivatives
pharmaceutically acceptable
Prior art date
Application number
LV931245A
Other languages
Latvian (lv)
Inventor
Dieter Binder
Franz Rovenszky
Hubert Ferber
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SU884355476A external-priority patent/SU1574176A3/en
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of LV5499A3 publication Critical patent/LV5499A3/en

Links

LV931245A 1987-04-03 1993-11-17 Adaptation of 2-thienyloxyethyl derivatives or their pharmaceutically acceptable islands LV5499A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT82087 1987-04-03
SU884355476A SU1574176A3 (en) 1987-04-03 1988-04-01 Method of obtaining derivatives of 2-thienyloxyacetic acid or their pharmaceutically acceptable salts

Publications (1)

Publication Number Publication Date
LV5499A3 true LV5499A3 (en) 1994-03-10

Family

ID=25594008

Family Applications (1)

Application Number Title Priority Date Filing Date
LV931245A LV5499A3 (en) 1987-04-03 1993-11-17 Adaptation of 2-thienyloxyethyl derivatives or their pharmaceutically acceptable islands

Country Status (2)

Country Link
LV (1) LV5499A3 (en)
MD (1) MD119C2 (en)

Also Published As

Publication number Publication date
MD119B1 (en) 1994-12-31
MD119C2 (en) 1995-07-31

Similar Documents

Publication Publication Date Title
LV5264A3 (en) Achievement of guanine derivatives or their pharmaceutically usable additive-additive
LV10614A (en) Derivative of 2-anilinopyrimidine
NO170911C (en) WHEELCHAIR
BR8907178A (en) STRUCTURE OF ROLLING BODIES
IT8822760A0 (en) CYCLODESTRINCLATRATES OF 5-CYANO-PROSTACYCLINE DERIVATIVES AND THEIR USE AS MEDICINES
ES2017606A4 (en) PREPARATION OF N - ACIL - AMINOMETILFOSFONATOS
GB8716918D0 (en) Soluble derivatives of silybin
YU146288A (en) Derivatives of benzimidazole-2-il-pyridinium
LV5499A3 (en) Adaptation of 2-thienyloxyethyl derivatives or their pharmaceutically acceptable islands
LV5528A3 (en) Saturation of L-Alanyl-1-Proline derivatives or their pharmaceutical islands
LV5106A3 (en) The method of obtaining indolizine derivatives or their pharmaceutically acceptable islands
LV5090A3 (en) The method of obtaining indolizine derivatives or their pharmaceutically acceptable islands
EP0307730A3 (en) Expression of mutarotase
ZA875319B (en) Use of dihydro benzopyran derivatives
IT8847653A0 (en) SIZZANTE INCLUDING 5 - PHARMACEUTICAL HYDROSCOMPOSITION OF ANOREXYTRPOPHANE
DK629387D0 (en) COURSE OF ACTION
LV5514A3 (en) Attenuation inhibits linkage to the acquisition of content-substituted diazabicycloalkylcholonecarbons or their pharmaceutically acceptable additive islands
LV5497A3 (en) Satisfaction of the acquisition of amidines or their pharmaceutically acceptable islands
GB8720773D0 (en) Preparation of derivatives
LV5504A3 (en) Saturation of piperazinylalkyl-3 (2H) -pyridazinones or their pharmaceutically acceptable islands
PT8008U (en) CANHAO OF TOY
LV5478A3 (en) Method of Acquiring Islands of Quinoline Derivatives or Pharmaceutically Acceptable Esters or Pharmaceutically Acceptable Derivatives or Esters thereof
LV5500A3 (en) Contribution to the production of 6-fluoro-1,4-dihydro-4-osko-7- (substituted piperazino) -quinoline-3-carbonyl derivatives or their pharmaceutically acceptable islands
LV5513A3 (en) Saturation of 2- (2-thienyl) imidazo (4,5-c) pyridine derivatives or pharmaceutically acceptable derivatives thereof
GB2217714B (en) Purification of 2-keto-l-gulonic acid